Clinical Trials Directory
We are doing this study learn more about how we can identify potential biomarkers in your eyes that may let us predict and/or diagnose one or more illnesses or medical conditions.
Although we will not be able to make these diagnoses now, one day in the future we may be able to use the information we have learned now to make these diagnoses in other people:<ul>
<li>Alzheimer's disease</li>
<li>Mild cognitive impairment</li>
<li>Parkinson's disease</li>
<li>Frontotemporal dementia</li>
<li>Dementia of Lewy body</li>
<li>Multiple sclerosis</li>
<li>Traumatic Brain Injury</li>
<li>PTSD</li>
<li>ALS</li>
<li>Huntington's</li>
<li>Down syndrome</li></ul>
We are doing this study to find out if an experimental drug called IMM-1-104 (the study drug) is a safe and effective option for patients with melanoma, pancreatic cancer, or lung cancer. We also want to find out what dose of the study drug works best.
We are doing this study to collect blood donations from those who have HIV to make sure laboratories across the United States and other countries are testing their blood to know and help support the course of HIV and other infectious diseases of the immune system as well as look at possible vaccines.
We are doing this study to test the effectiveness of the IMPACt-LBP Program. This program was built to help adult patients who have low back pain receive the right care at the right time with the right provider.
We are doing this study to test a program that is designed to help young cancer survivors improve how well they follow diet and exercise guidelines, manage their weight, and cope with physical and emotional symptoms that can interfere with diet, exercise, and weight management.
We are doing this study to find the most effective, safe dose of an experimental drug called INCB000928 (the study drug). We want to know how well this study drug works alone and in combination with ruxolitinib in people with anemia due to myeloproliferative disorders.
We are doing this study to understand how your sleep can effect biomarkers of heart disease in people with posttraumatic stress disorder (PTSD) and insomnia.
We are doing this study to find out if an inspiratory muscle training (IMT) program is beneficial for people with LOPD. We want to know if IMT can help reduce the effects of weakness in breathing muscles and improve the quality of life for people with LOPD.